Article

Air Liquide is reportedly exploring the sale of its biomethane assets as it refocuses on its core gas supply business for large industries and healthcare. The company, advised by JPMorgan, could generate around €500 million from the sale.

While biomethane production remains a significant sector, investments have slowed, and the International Energy Agency has revised its long-term demand forecasts. Air Liquide operates 29 biomethane production units globally and is leaning towards a sale to a single investor, though offers for individual assets may also be considered.